These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 730364)

  • 21. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.
    Holmes RK; Vasil ML; Finkelstein RA
    J Clin Invest; 1975 Mar; 55(3):551-60. PubMed ID: 803978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence in the mouse gut as an important factor in oral immunogenicity of strains of V. cholerae.
    Bloom L; Rowley D
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):325-33. PubMed ID: 533484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area.
    Faruque SM; Chowdhury N; Kamruzzaman M; Dziejman M; Rahman MH; Sack DA; Nair GB; Mekalanos JJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2123-8. PubMed ID: 14766976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo adherence and colonization of Vibrio cholerae strains that differ in hemagglutinating activity and motility.
    Teppema JS; Guinée PA; Ibrahim AA; Pâques M; Ruitenberg EJ
    Infect Immun; 1987 Sep; 55(9):2093-102. PubMed ID: 3623694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel factors involved in colonization and acid tolerance of Vibrio cholerae.
    Merrell DS; Hava DL; Camilli A
    Mol Microbiol; 2002 Mar; 43(6):1471-91. PubMed ID: 11952899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seasonal fluctuations in the enteropathogenic properties of vibrios].
    Ved'mina EA; Pasternak NA; Andrusenko IT; Sobolev VR; Shenderovich VA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Sep; (9):34-9. PubMed ID: 7445877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The characteristics of the protectiveness of a preparation of Vibrio cholerae outer membrane based on the data from a study using the ligated intestinal loop].
    Urbanovich LIa; Sappo SG; Kolesnik RS; Golubinskiĭ EP; Markov EIu; Ganin VS; Ivanova TA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):43-6. PubMed ID: 9245140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of early cholera infection in the removable intestinal tie-adult rabbit diarrhea model.
    Spira WM; Sack RB
    Infect Immun; 1982 Mar; 35(3):952-7. PubMed ID: 7068225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic control of Vibrio cholerae pathogenicity: the temperate filamentous phage CTX, coding for cholera toxin and the "island of pathogenicity"].
    Smirnova NI
    Mol Gen Mikrobiol Virusol; 1999; (4):3-11. PubMed ID: 10621931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel.
    Sigel SP; Finkelstein RA; Parker CD
    Infect Immun; 1981 May; 32(2):474-9. PubMed ID: 7251134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alternative sigma factor sigma(E) plays an important role in intestinal survival and virulence in Vibrio cholerae.
    Kovacikova G; Skorupski K
    Infect Immun; 2002 Oct; 70(10):5355-62. PubMed ID: 12228259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human evolutionary loss of epithelial Neu5Gc expression and species-specific susceptibility to cholera.
    Alisson-Silva F; Liu JZ; Diaz SL; Deng L; Gareau MG; Marchelletta R; Chen X; Nizet V; Varki N; Barrett KE; Varki A
    PLoS Pathog; 2018 Jun; 14(6):e1007133. PubMed ID: 29912959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Potentials and conditions for the reversion of pathogenic properties of the causative agent of cholera in an experiment].
    Uraleva VS; Cherepakhina IIa; Gulida MM; Kutyreva IV; Pomukhina OI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Dec; (12):54-9. PubMed ID: 6528781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.
    Cray WC; Tokunaga E; Pierce NF
    Infect Immun; 1983 Aug; 41(2):735-41. PubMed ID: 6874074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dependence of the expression of the biological features of Vibrio cholerae on the conditions of their cultivation].
    Mironova AV; Menshikova EA; Sokolenko AV
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):77-9. PubMed ID: 12886638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vibrio cholerae represses polysaccharide synthesis to promote motility in mucosa.
    Liu Z; Wang Y; Liu S; Sheng Y; Rueggeberg KG; Wang H; Li J; Gu FX; Zhong Z; Kan B; Zhu J
    Infect Immun; 2015 Mar; 83(3):1114-21. PubMed ID: 25561707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Vibrio cholerae virulence genes in response to environmental signals.
    Peterson KM
    Curr Issues Intest Microbiol; 2002 Sep; 3(2):29-38. PubMed ID: 12400636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasmid-mediated changes in virulence of Vibrio cholerae.
    Hamood AN; Sublett RD; Parker CD
    Infect Immun; 1986 May; 52(2):476-83. PubMed ID: 2939028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.
    Spira WM; Fedorka-Cray PJ
    Infect Immun; 1983 Nov; 42(2):501-9. PubMed ID: 6642640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stringent response interacts with the ToxR regulon to regulate Vibrio cholerae virulence factor expression.
    Raskin DM; Mishra A; He H; Lundy Z
    Arch Microbiol; 2020 Aug; 202(6):1359-1368. PubMed ID: 32157346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.